Friedrich, S. O., Venter, A., Kayigire, X. A., Dawson, R., Donald, P. R., & Diacon, A. H. (2011). Suitability of Xpert MTB/RIF and Genotype MTBDRplus for Patient Selection for a Tuberculosis Clinical Trial. American Society for Microbiology.
Chicago-stil citatFriedrich, Sven O., Amour Venter, Xavier A. Kayigire, Rodney Dawson, Peter R. Donald, och Andreas H. Diacon. Suitability of Xpert MTB/RIF and Genotype MTBDRplus for Patient Selection for a Tuberculosis Clinical Trial. American Society for Microbiology, 2011.
MLA-referensFriedrich, Sven O., et al. Suitability of Xpert MTB/RIF and Genotype MTBDRplus for Patient Selection for a Tuberculosis Clinical Trial. American Society for Microbiology, 2011.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.